CELL INTELLIGENCE · 肿瘤细胞治疗研究

既往参加 CAR-T 细胞研究者的基因治疗长期随访方案

Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies

这是一项观察性研究，观察细胞治疗用于白血病、多发性骨髓瘤、血液系统恶性肿瘤的真实世界诊疗与结局。当前状态：邀请入组。计划入组 1000 例。试验地点：美国 · 贝塞斯达（共 1 个中心）。登记号：NCT02473757。

免疫效应细胞相关肠炎的组织学谱系与 T 细胞克隆性特征

Characterization of Histologic Spectrum and T-Cell Clonality in Immune Effector Cell-Associated Enteritis.

下一代基于抗体的癌症治疗：抗体-药物偶联物和双特异性抗体在血液系统恶性肿瘤和实体瘤中的应用

Next-generation antibody-based therapeutics in cancer: antibody-drug conjugates bispecific antibodies across hematologic malignancies and solid tumors

AML/MDS 细胞治疗的最新进展

Recent advances in cell therapy for AML/MDS.

一种新型三基因敲除同种异体 BCMA CAR-T 细胞疗法（CT0590）用于多发性骨髓瘤：临床前及 1 期研究

A novel triple-knockout allogeneic BCMA CAR T-cell therapy (CT0590) for multiple myeloma: preclinical and phase 1 study.

线粒体适应度作为癌症中的功能性免疫检查点：代谢可塑性、肿瘤演化与免疫治疗

Mitochondrial Fitness as a Functional Immune Checkpoint in Cancer: Metabolic Plasticity, Tumor Evolution, and Immunotherapy.

原发性浆细胞白血病

Primary Plasma Cell Leukemia.

血液系统恶性肿瘤中的 CD74：从 MHC 分子伴侣到治疗靶点

CD74 in hematological malignancies: from MHC chaperone to therapeutic target.

CAR-T 细胞治疗相关凝血病：从免疫血栓风暴机制到精准管理策略

CAR-T cell therapy-associated coagulopathy: From immunothrombotic storm mechanisms to precision management strategies.

CAR-T 细胞免疫治疗后 T 细胞淋巴瘤的综合综述

A Comprehensive Review of T-Cell Lymphoma Following CAR T-Cell Immunotherapy.